NextCure Inc. Company Profile
NASDAQ: NXTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.78+0.22 (+3.35%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 6.78 0.00%
NextCure at a glance
NextCure Inc. (NASDAQ: NXTC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2019. At a market capitalization of $31.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001661059, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- NextCure Inc.
- Ticker
- NASDAQ: NXTC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2019
- Market cap
- $31.03M
- SEC CIK
- 0001661059
Companies similar to NextCure
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RMTIRockwell Medical Inc. | 8.02 | -2.43% | $32.32M | vs NXTC |
| MIRAMIRA Pharmaceuticals Inc. | 0.703 | -0.99% | $29.54M | vs NXTC |
| IGCIGC Pharma Inc. | 0.2849 | +1.75% | $29.45M | vs NXTC |
| RNAZTransCode Therapeutics Inc. | 1.71 | -2.84% | $28.95M | vs NXTC |
| NNVCNanoViricides Inc. | 1.31 | -9.03% | $33.44M | vs NXTC |
| IMMPImmutep Limited ADR | 3.84 | -6.56% | $28.30M | vs NXTC |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.08 | +0.93% | $33.96M | vs NXTC |
| BCTXBriaCell Therapeutics Corp. | 3.92 | -2.00% | $34.10M | vs NXTC |